Internal Medicine · Palm Springs, CA
NPI
1407841315
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1492 N Palm Canyon Dr
Palm Springs, CA, 92262
Phone (760) 322-5156
Groups this clinician bills Medicare through
Medicare paid, 2024
$541K
14,625 services
Medicare patients, 2024
227
Average age 76
Drug cost, 2024
$1.7M
3,588 prescriptions
Company payments, 2025
$53.81
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William J Grimm was code 64450 (musculoskeletal), 8,132 times for 39 patients. In total William J Grimm billed 14,625 services in 65 codes, and Medicare paid $541K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64450 Musculoskeletal | Office | 8,132 | 39 | $34.69 | $282K |
| 97112 PT Treatment | Office | 2,430 | 41 | $23.69 | $58K |
| 99458 E&M - Miscellaneous | Office | 705 | 65 | $31.91 | $22K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 595 | 17 | $0.10 | $60.93 |
| 99457 E&M - Miscellaneous | Office | 524 | 68 | $39.60 | $21K |
| 99214 Office E&M - Established | Office | 394 | 175 | $95.62 | $38K |
| 99454 E&M - Miscellaneous | Office | 276 | 53 | $39.80 | $11K |
| 99441 Telephone Services | Office | 264 | 64 | $43.58 | $12K |
| 99215 Office E&M - Established | Office | 224 | 119 | $140.59 | $31K |
| 96372 Injection Administration | Office | 173 | 32 | $10.74 | $1,859 |
| 99213 Office E&M - Established | Office | 155 | 101 | $68.27 | $11K |
| 99212 Office E&M - Established | Office | 140 | 37 | $45.68 | $6,395 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 120 | 120 | $132.13 | $16K |
| 99497 Care Management/Coordination | Office | 95 | 93 | $75.17 | $7,141 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 41 | $29.40 | $1,235 |
By year: 2022 $190K for 3,136 services; 2023 $441K for 16,756 services; 2024 $541K for 14,625 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 22 | 22 | $17.69 | $389 |
Medicare prescription drug claims, 2024
In 2024, the drug William J Grimm prescribed most often to Medicare patients was Rosuvastatin Calcium, with 239 prescriptions and refills. In total William J Grimm wrote 3,588 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 239 | 701 | 75 | $4,370 |
| Levothyroxine Sodium Generic | 92 | 274 | 26 | $1,113 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 88 | 90 | Under 11 | $360K |
| Losartan Potassium Generic | 79 | 235 | 26 | $1,074 |
| Amlodipine Besylate Generic | 78 | 234 | 24 | $712 |
| Lorazepam Generic | 75 | 83 | 17 | $498 |
| Azithromycin Generic | 75 | 75 | 57 | $413 |
| Pantoprazole Sodium Generic | 65 | 185 | 23 | $869 |
| Atorvastatin Calcium Generic | 64 | 192 | 20 | $630 |
| Gabapentin Generic | 63 | 123 | 21 | $951 |
| Allopurinol Generic | 62 | 187 | 19 | $609 |
| Dovato Dolutegravir Sodium/Lamivudine | 60 | 64 | Under 11 | $205K |
| Tamsulosin Hcl Generic | 58 | 170 | 21 | $1,250 |
| Metformin Hcl Generic | 56 | 166 | 18 | $518 |
| Metoprolol Succinate Generic | 52 | 154 | 15 | $850 |
Brand drugs: 699 claims; generic drugs: 2,857 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William J Grimm $53.81 ($53.81 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $27.01.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.